Acarix (Q3 Initial take): Record sales and improved OPEX - Redeye
Bildkälla: Stockfoto

Acarix (Q3 Initial take): Record sales and improved OPEX - Redeye

Redeye provides its initial take on Acarix’s Q3 report, which showed record quarterly sales driven by the company’s first order and entry into the MENA region, as well as continued momentum in the US. The company also demonstrated improved cost efficiency following the implementation of its cost-saving initiatives, resulting in OPEX coming in better than our estimates. We expect a positive share price reaction of approximately 5–10% today.

Redeye provides its initial take on Acarix’s Q3 report, which showed record quarterly sales driven by the company’s first order and entry into the MENA region, as well as continued momentum in the US. The company also demonstrated improved cost efficiency following the implementation of its cost-saving initiatives, resulting in OPEX coming in better than our estimates. We expect a positive share price reaction of approximately 5–10% today.
Börsvärldens nyhetsbrev